Innovations

Drug triggers immune cells to attack prostate cancer

0
Scientist researcher chemist doctor working with transparent glassware mixing liquid solution during microbiology experiment in hospital laboratory. Medical equipment on table. Medicine concept

A single drug compound simultaneously attacks hard-to-treat prostate cancer on several fronts, according to a new study in mice and human cells. It triggers immune cells to attack, helps the immune cells penetrate the tumor, and cuts off the tumor’s ability to burn testosterone as fuel, according to new research from Washington University School of Medicine in St. Louis. The drug may offer a promising new strategy for treating patients whose tumors don’t respond to standard therapy.

Today’s best deals: $1.99 Hulu subscriptions, $91 off AirPods Pro, and the first discount on the Roomba Combo J7+

Previous article

Evidence found of structural changes in the brain during pregnancy

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations